期刊文献+

我国抗体制药企业专利保护状况调研及思考 被引量:2

下载PDF
导出
摘要 为深入研究我国抗体制药产业专利状况和相关企业实施专利战略的情况,笔者一行赴国内主要的抗体药物基地——上海,针对多家抗体制药企业开展实地调研。本文分析了我国抗体制药企业的专利保护状况,并提出了相关建议。
出处 《中国发明与专利》 2014年第6期23-28,共6页 China Invention & Patent
  • 相关文献

参考文献1

二级参考文献18

  • 1[1]Uhlen M,Ponten F.Antibody-based proteomics for human tissue profiling.Mol Cell Proteomics,2005,4(4):384-393.
  • 2[2]Bernasconi NL,Traggiai E,Lanzavecchia A,et al.Maintenance of serological memory by polyclonal activation of human memory B cells.Science,2002,298(5601):2199-2202.
  • 3[3]Spieker-Polet H,Sethupathi P,Yam PC,et al.Rabbit monoclonal antibodies:generating a fusion partner to produce rabbit-rabbit hybridomas.Proc Natl Acad Sci U S A,1995,92(20):9348-9352.
  • 4[4]Wring SA,Kilpatrick KE,Hutchins JT,et al.Shorter development of immunoassay for drugs:application of the novel RIMMS technique enables rapid production of monoclonal antibodies to ranitidine.J Pharm Biomed Anal,1999,19(5):695-707.
  • 5[5]Perez JM,Renisio JG,Prompers JJ,et al.Thermal unfolding of a llama antibody fragment:a two-state reversible process.Biochemistry,2001,40(1):74-83.
  • 6[6]Chhatre S,Jones C,Francis R,et al.The integrated simulation and assessment of the impacts of process change in biotherapeutic antibody production.Biotechnol Prog,2006,22(6):1612-1620.
  • 7[7]Xu J,Shen ZY,Chen XG,et al.A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation.Hepatology,2007,45(2):269-276.
  • 8[8]Chong HS,Milenic DE,Garmestani K,et al.In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.Nucl Med Biol,2006,33(4):459-467.
  • 9[9]Wu AM,Senter PD.Arming antibodies:prospects and challenges for immunoconjugates.Nat Biotechnol,2005,23(9):1137-1146.
  • 10[10]The next generation? Nat Biotechnol,2006,24(11):1300.

共引文献10

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部